· Commonly Used Appendlx Abbreviations in Gyn(Ccology
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Velvi Product Information Brochure
Vaginal Dilatator www.velvi-vaginismus.com The Velvi Kit is a set of six vaginal dilators, a removable handle and an instructions for use manual. Each Velvi dilator is a purple cylindrical element, smoothly shaped in plastic and specifically adapted to vaginal dilation exercises. Velvi Kit - 6 graduated vaginal dilators Self treatment for painful sexual intercourse : Vaginismus Vulvodynia and dyspareunia Vaginal stenosis vaginal agenesis (MRKH syndrome) After gynecological surgery or trauma following childbirth. Velvi dilators dimensions: Size 1: 4 cm in length with a base diameter of 1 cm. Size 2: 5.5 cm in length with a base diameter of 1.5 cm. Size 3: 7 cm in length with a base diameter of 2 cm. Size 4: 8.5 cm in length with a base diameter of 2.5 cm. Size 5: 10 cm in length with a base diameter of 3 cm. Size 6: 11.5 cm in length with a base diameter of 3.5 cm. The handle can be locked on each dilator Velvi With a simple rotating movement. How to use properly a Velvi dilator ? First, generously lubricate the dilator and the entrance to your vagina. Then gently spread your labia and insert the dilator very slowly inside your vaginal canal. Keep in mind that pushing on your perineum will help you while introducing it. Do not try to guide the dilator, in general it will keep going in the right direction by itself. When starting a new exercise with a dilator, do not immediately try to make any sort of movements. Wait a bit and let some time to your vagina to get used to the fact that a dilator is inserted without moving. -
Self-Care Practices and Immediate Side Effects in Women with Gynecological Cancer
Rev. Enferm. UFSM - REUFSM Santa Maria, RS, v. 11, e35, p. 1-21, 2021 DOI: 10.5902/2179769248119 ISSN 2179 -7692 Artigo Original Submiss ão : 07 /21 /20 20 Aprovação: 03 /18 /202 1 Publicação: 04 /20 /202 1 SelfSelf----carecare practices and immediate side effects in women with gynecological cancer in brachytherapy* Práticas de autocuidado e os efeitos colaterais imediatos em mulheres com câncer ginecológico em braquiterapia Prácticas de autocuidado y los efectos colaterales inmediatos en mujeres con cáncer ginecológico en braquiterapia Rosimeri Helena da Silva III, Luciana Martins da Rosa IIIIII , Mirella Dias IIIIIIIII , Nádia Chiodelli Salum IVIVIV , Ana Inêz Severo Varela VVV, Vera Radünz VIVIVI Abstract : ObjectiveObjective: to reveal the immediate side effects and self-care practices adopted by women with gynecological cancer submitted to brachytherapy. MethodMethod:Method narrative research, conducted with 12 women, in southern Brazil, between December/2018 and January/2019, including semi-structured interviews submitted to content analysis. ResultsResults: three thematic categories emerged from the analysis: Care oriented and adopted by women in pelvic brachytherapy; Immediate side effects perceived by women in pelvic brachytherapy; Care not guided by health professionals. The care provided by the nurses most reported by the women was vaginal dilation, use of a shower and vaginal lubricant, tea consumption, cleaning, and storage of the vaginal dilator. The side effects most frequently mentioned in the interviews were urinary and intestinal changes in the skin and mucous membranes. ConclusionConclusion: nursing care in brachytherapy must prioritize care to prevent and control genitourinary and cutaneous changes, including self-care practices. I Professional Master in Nursing Care Management, Nurse at the Oncological Research Center, Florianópolis, Santa Catarina, Brazil. -
Female Pelvic Relaxation
FEMALE PELVIC RELAXATION A Primer for Women with Pelvic Organ Prolapse Written by: ANDREW SIEGEL, M.D. An educational service provided by: BERGEN UROLOGICAL ASSOCIATES N.J. CENTER FOR PROSTATE CANCER & UROLOGY Andrew Siegel, M.D. • Martin Goldstein, M.D. Vincent Lanteri, M.D. • Michael Esposito, M.D. • Mutahar Ahmed, M.D. Gregory Lovallo, M.D. • Thomas Christiano, M.D. 255 Spring Valley Avenue Maywood, N.J. 07607 www.bergenurological.com www.roboticurology.com Table of Contents INTRODUCTION .................................................................1 WHY A UROLOGIST? ..........................................................2 PELVIC ANATOMY ..............................................................4 PROLAPSE URETHRA ....................................................................7 BLADDER .....................................................................7 RECTUM ......................................................................8 PERINEUM ..................................................................9 SMALL INTESTINE .....................................................9 VAGINAL VAULT .......................................................10 UTERUS .....................................................................11 EVALUATION OF PROLAPSE ............................................11 SURGICAL REPAIR OF PELVIC PROLAPSE .....................15 STRESS INCONTINENCE .........................................16 CYSTOCELE ..............................................................18 RECTOCELE/PERINEAL LAXITY .............................19 -
Dyspareunia Treated by Bilateral Pudendal Nerve Block Gregory Amend, Yimei Miao, Felix Cheung, John Fitzgerald, Brian Durkin, S
www.symbiosisonline.org Symbiosis www.symbiosisonlinepublishing.com Case Report SOJ Anesthesiology and Pain Management Open Access Dyspareunia Treated By Bilateral Pudendal Nerve Block Gregory Amend, Yimei Miao, Felix Cheung, John Fitzgerald, Brian Durkin, S. Ali Khan and Srinivas Pentyala* Departments of Urology and Anesthesiology, Stony Brook Medical Center, USA Received: November 19, 2013; Accepted: March 13, 2014, Published: March 14, 2014 *Corresponding author: Srinivas Pentyala, Department of Anesthesiology, Stony Brook Medical Center, Stony Brook, NY 11794-8480, New York, USA; Tel: 631-444-2974; Fax: 631-444-2907; E-mail: [email protected] patient’s last sexual attempt was 2 weeks prior to presentation. Abstract The patient was in a stable long term marriage with no history of physical, sexual, or emotional abuse. Patient denied use of alcohol, dyspareunia of unclear etiology, who was successfully managed with tobacco, and illicit drugs. There was no history of psychiatric In this report, we present a patient with refractory superficial a bilateral pudendal nerve block. Initial workup failed to identify conditions, endocrine abnormalities, neurologic illnesses, pelvic trauma, sexually transmitted infections, incontinence, pudendalan obvious nerve source block for alleviated the pain the and problem first-line to threetherapy years for follow- post- up.menopausal In this report, superficial we review dyspareunia the current was dyspareunia not effective. literature A bilateral and vaginal stenosis. The patient previously had multiple abdominal propose a diagnostic algorithm. incisions,pelvic floor including disorders, two electiveurological C-sections problems, and endometriosis, a total abdominal or Keywords: Dyspareunia; Organ prolapse; Vaginitis; Pudendal nerve hysterectomy for dysfunctional uterine bleeding 4 years prior block; Vulvar vestibulitis to presentation. -
New Insights Into Human Female Reproductive Tract Development
UCSF UC San Francisco Previously Published Works Title New insights into human female reproductive tract development. Permalink https://escholarship.org/uc/item/7pm5800b Journal Differentiation; research in biological diversity, 97 ISSN 0301-4681 Authors Robboy, Stanley J Kurita, Takeshi Baskin, Laurence et al. Publication Date 2017-09-01 DOI 10.1016/j.diff.2017.08.002 Peer reviewed eScholarship.org Powered by the California Digital Library University of California Differentiation 97 (2017) xxx–xxx Contents lists available at ScienceDirect Differentiation journal homepage: www.elsevier.com/locate/diff New insights into human female reproductive tract development MARK ⁎ Stanley J. Robboya, , Takeshi Kuritab, Laurence Baskinc, Gerald R. Cunhac a Department of Pathology, Duke University, Davison Building, Box 3712, Durham, NC 27710, United States b Department of Cancer Biology and Genetics, The Comprehensive Cancer Center, Ohio State University, 460 W. 12th Avenue, 812 Biomedical Research Tower, Columbus, OH 43210, United States c Department of Urology, University of California, 400 Parnassus Avenue, San Francisco, CA 94143, United States ARTICLE INFO ABSTRACT Keywords: We present a detailed review of the embryonic and fetal development of the human female reproductive tract Human Müllerian duct utilizing specimens from the 5th through the 22nd gestational week. Hematoxylin and eosin (H & E) as well as Urogenital sinus immunohistochemical stains were used to study the development of the human uterine tube, endometrium, Uterovaginal canal myometrium, uterine cervix and vagina. Our study revisits and updates the classical reports of Koff (1933) and Uterus Bulmer (1957) and presents new data on development of human vaginal epithelium. Koff proposed that the Cervix upper 4/5ths of the vagina is derived from Müllerian epithelium and the lower 1/5th derived from urogenital Vagina sinus epithelium, while Bulmer proposed that vaginal epithelium derives solely from urogenital sinus epithelium. -
Pessary Information
est Ridge obstetrics & gynecology, LLP 3101 West Ridge Road, Rochester, NY 14626 1682 Empire Boulevard, Webster, NY 14580 www.wrog.org Tel. (585) 225‐1580 Fax (585) 225‐2040 Tel. (585) 671‐6790 Fax (585) 671‐1931 USE OF THE PESSARY The pessary is one of the oldest medical devices available. Pessaries remain a useful device for the nonsurgical treatment of a number of gynecologic conditions including pelvic prolapse and stress urinary incontinence. Pelvic Support Defects The pelvic organs including the bladder, uterus, and rectum are held in place by several layers of muscles and strong tissues. Weaknesses in this tissue can lead to pelvic support defects, or prolapse. Multiple vaginal deliveries can weaken the tissues of the pelvic floor. Weakness of the pelvic floor is also more likely in women who have had a hysterectomy or other pelvic surgery, or in women who have conditions that involve repetitive bearing down, such as chronic constipation, chronic coughing or repetitive heavy lifting. Although surgical repair of certain pelvic support defects offers a more permanent solution, some patients may elect to use a pessary as a very reasonable treatment option. Classification of Uterine Prolapse: Uterine prolapse is classified by degree. In first‐degree uterine prolapse, the cervix drops to just above the opening of the vagina. In third‐degree prolapse, or procidentia, the entire uterus is outside of the vaginal opening. Uterine prolapse can be associated with incontinence. Types of Vaginal Prolapse: . Cystocele ‐ refers to the bladder falling down . Rectocele ‐ refers to the rectum falling down . Enterocele ‐ refers to the small intestines falling down . -
Obstetrics and Gyneclogy
3/28/2016 Obstetrics and Gynecology Presented by: Peggy Stilley, CPC, CPC-I, CPMA, CPB, COBGC Objectives • Procedures • Pregnancy • Payments • Patient Relationships 1 3/28/2016 Female Genital Anatomy Terminology and Abbreviations • Endometriosis • Neoplasm • BUS • TAH/BSO • G3P2 2 3/28/2016 Procedures • Hysterectomy • Prolapse repairs • IUDs • Colposcopy Hysterectomy • Approach • Open • Vaginal • Total Laparoscopic • Laparoscopic assisted • Extent • Total • Subtotal • Supracervical • Diagnosis 3 3/28/2016 CPT Codes • Abdominal 58150 – • With or without removal tubes/ovaries 58240 • Some additional services • Vaginal 58260-58270 • Size of uterus < 250 grams, > 250 grams 58275-58294 • Additional services CPT Codes • LAVH 58541-58544 • Detach uterus , cervix, and structures through the scope 58548-58554 • Uterus removed thru the vagina • TLH • Detach structures laparoscopically entire 58570- 58573 uterus, cervix, bodies • Removed thru the vagina or abdomen • LSH • Detaching structures through the scope, 58541 – 58544 leaving the cervix • Morcellating – removing abdominally 4 3/28/2016 Hysterectomy Additional procedures performed • Tubes & Ovaries removed • Enterocele repair • Repairs for incontinence • Marshall-Marchetti-Krantz • Colporrhaphy • Colpo-urethropexy • Urethral Sling • TVT, TOT 5 3/28/2016 Procedures • 57288 Sling • 57240 Anterior Repair • 57250 Posterior Repair • +57267 Add on code for mesh/graft • 57260 Combo of A&P • 57425 Laparoscopic Colpopexy • 57280 Colpopexy, Abdominal approach • 57282 Colpopexy, vaginal approach Example 1 PREOPERATIVE DIAGNOSES: 1. Menorrhagia unresponsive to medical treatment with resulting chronic blood loss anemia POSTOPERATIVE DIAGNOSES: 1. Menorrhagia 2. Blood loss anemia TITLE OF SURGERY: Total abdominal hysterectomy ANESTHESIA: GENERAL ENDOTRACHEAL ANESTHESIA. INDICATIONS: The patient is a lovely 52-year-old female who presented with menorrhagia that is non- responsive to medical treatment. -
Gynecological-DBQ
INTERNAL VETERANS AFFAIRS USE GYNECOLOGICAL CONDITIONS DISABILITY BENEFITS QUESTIONNAIRE IMPORTANT - THE DEPARTMENT OF VETERANS AFFAIRS (VA) WILL NOT PAY OR REIMBURSE ANY EXPENSES OR COST INCURRED IN THE PROCESS OF COMPLETING AND/OR SUBMITTING THIS FORM. PLEASE READ THE PRIVACY ACT AND RESPONDENT BURDEN INFORMATION ON REVERSE BEFORE COMPLETING FORM. NAME OF PATIENT/VETERAN PATIENT/VETERAN'S SOCIAL SECURITY NUMBER NOTE TO PHYSICIAN - Your patient is applying to the U.S. Department of Veterans Affairs (VA) for disability benefits. VA will consider the information you provide on this questionnaire as part of their evaluation in processing the claim. VA reserves the right to confirm the authenticity of ALL DBQs completed by private health care providers. IS THIS DBQ BEING COMPLETED IN CONJUNCTION WITH A VA21-2507, C&P EXAMINATION REQUEST? YES NO If no, how was the examination completed (check all that apply)? In-person examination Records reviewed Other, please specify: Comments: ACCEPTABLE CLINICAL EVIDENCE (ACE) INDICATE METHOD USED TO OBTAIN MEDICAL INFORMATION TO COMPLETE THIS DOCUMENT: Review of available records (without in-person or video telehealth examination) using the Acceptable Clinical Evidence (ACE) process because the existing medical evidence provided sufficient information on which to prepare the DBQ and such an examination will likely provide no additional relevant evidence. Review of available records in conjunction with a telephone interview with the Veteran (without in-person or telehealth examination) using the ACE process because the existing medical evidence supplemented with a telephone interview provided sufficient information on which to prepare the DBQ and such an examination would likely provide no additional relevant evidence. -
Cervical Ectropion May Be a Cause of Desquamative Inflammatory Vaginitis. Leia Mitchell
Himmelfarb Health Sciences Library, The George Washington University Health Sciences Research Commons Obstetrics and Gynecology Faculty Publications Obstetrics and Gynecology 4-28-2017 Cervical Ectropion May Be a Cause of Desquamative Inflammatory Vaginitis. Leia Mitchell Michelle King Heather Brillhart George Washington University Andrew Goldstein Follow this and additional works at: https://hsrc.himmelfarb.gwu.edu/smhs_obgyn_facpubs Part of the Obstetrics and Gynecology Commons APA Citation Mitchell, L., King, M., Brillhart, H., & Goldstein, A. (2017). Cervical Ectropion May Be a Cause of Desquamative Inflammatory Vaginitis.. Sexual Medicine, (). http://dx.doi.org/10.1016/j.esxm.2017.03.001 This Journal Article is brought to you for free and open access by the Obstetrics and Gynecology at Health Sciences Research Commons. It has been accepted for inclusion in Obstetrics and Gynecology Faculty Publications by an authorized administrator of Health Sciences Research Commons. For more information, please contact [email protected]. Cervical Ectropion May Be a Cause of Desquamative Inflammatory Vaginitis Leia Mitchell, MSc,1 Michelle King, MSc,1,2 Heather Brillhart, MD,3 and Andrew Goldstein, MD1,3 ABSTRACT Desquamative inflammatory vaginitis is a poorly understood chronic vaginitis with an unknown etiology. Symptoms of desquamative inflammatory vaginitis include copious yellowish discharge, vulvovaginal discomfort, and dyspareunia. Cervical ectropion, the presence of glandular columnar cells on the ectocervix, has not been reported as a cause of desquamative inflammatory vaginitis. Although cervical ectropion can be a normal clinical finding, it has been reported to cause leukorrhea, metrorrhagia, dyspareunia, and vulvovaginal irritation. Patients with cervical ectropion and des- quamative inflammatory vaginitis are frequently misdiagnosed with candidiasis or bacterial vaginosis and repeatedly treated without resolution of symptoms. -
EDUCATION Clinical Challenge
EDUCATION Questions for this month’s clinical challenge are based on articles in this issue. The style and scope of questions is in keeping with the MCQ of the College Fellowship exam. The quiz is endorsed by the RACGP Quality Assurance and Clinical challenge Continuing Professional Development Program and has been allocated 4 CPD points per issue. Answers to this clinical challenge will be published next month, and are available immediately following successful completion online at: www.racgp.org.au/clinicalchallenge. Jenni Parsons SINGLE COMPLETION ITEMS DIRECTIONS Each of the questions or incomplete statements below is followed by five suggested answers or completions. Select the most appropriate statement as your answer. Case 1 – Donna Watson A. have no treatment until the results of the A. abdominal ultrasound Donna, 23 years of age, has been taking tests come back so that the appropriate B. transvaginal ultrasound the combined oral contraceptive pill antibiotic can be given C. a qualitative urine BHCG (COCP) for many years without problems. B. be treated with azithromycin 1 g stat, doxy- D. a quantitative serum BHCG Over the past 6 weeks she has had cycline 100 mg twice daily for 14 days and E. full blood examination and C reactive protein. intermittent vaginal bleeding on several metronidazole 400 mg twice daily for 14 days days per week despite no missed pills. She Question 6 also noted pain on intercourse during that C. be treated with amoxycillin 500 mg and met- You confirm that Sarah is pregnant. She is time and over the past 2 weeks has had ronidazole 400 mg three times daily haemodynamically stable. -
Original Article
ORIGINAL ARTICLE MOIST VAGINAL PACKING FOR UTERO-VAGINAL PROLAPSE-A CLINICAL STUDY Manidip Pal, Soma Bandyopadhyay 1. Associate Professor, Department of Obestetrics & Gynaecology, College of Medicine & JNM Hospital, WBUHS, Kalyani, Nadia, West Bengal. 2. Associate Professor, Department of Obestetrics & Gynaecology, Jawaharlal Nehru Institute of Medical Sciences, Porompat, Imphal, Manipur. CORRESPONDING AUTHOR Manidip Pal, Associate Professor, OBGYN, College of Medicine & JNM Hospital, WBUHS, Kalyani, Nadia, West Bengal, PIN –741235. E-mail: [email protected] Ph: 0091 9051678490 ABSTRACT: BACKGROUND : Utero-vaginal prolapse is a common condition in aged women and often they come to us with decubitus ulcer. Prolonged vaginal packing not only will heal the decubitus ulcer but also it may help in returning the normal rugosity of the vaginal skin. AIMS: To assess the role of prolonged moist vaginal packing in utero-vaginal prolpase. SETTINGS & DESIGN: It was an OPD based prospective study conducted at the gynecology OPD of College of Medicine & JNM Hospital, WBUHS, Kalyani, Nadia, West Bengal and Jawaharlal Nehru Institute of Medical Sciences, Porompat, Imphal, Manipur. METHODS & MATERIAL: Hundred (100) patients of utero-vaginal prolapse with decubitus ulcer were studied. After initial staging (POP- Q staging), daily moist (5% povidone-iodine solution soaked gauze) vaginal packing at home was advised. After 2 weeks, re-examination done for decubitus ulcer healing. Packing continued till operation (interval 1- 1½ month). Preoperative staging and modification of operation were noted. On follow up complication (mainly recurrence) was noted. RESULTS: Initial staging was stage 3 - 39%, stage 4 - 61%. Preoperative scoring revealed stage 3 became stage 2 in 54% cases and stage 4 became stage 3 in 49% cases. -
Vaginal Intraepithelial Neoplasia: a Therapeutical Dilemma
ANTICANCER RESEARCH 33: 29-38 (2013) Vaginal Intraepithelial Neoplasia: A Therapeutical Dilemma ANTONIO FREGA1*, FRANCESCO SOPRACORDEVOLE2*, CHIARA ASSORGI1, DANILA LOMBARDI1, VITALIANA DE SANCTIS3, ANGELICA CATALANO1, ELEONORA MATTEUCCI1, GIUSI NATALIA MILAZZO1, ENZO RICCIARDI1 and MASSIMO MOSCARINI1 Departments of 1Gynecological, Obstetric and Urological Sciences, and 3Radiotherapy, Sant’Andrea Hospital, Sapienza University of Rome, Rome, Italy; 2Department of Gynaecological Oncology, National Cancer Institute, Aviano, Italy Abstract. Vaginal intraepithelial neoplasia (VaIN) thirds of the epithelium. Carcinoma in situ, which involves represents a rare and asymptomatic pre-neoplastic lesion. Its the full thickness of the epithelium, is included in VaIN 3. natural history and potential evolution into invasive cancer The natural history of VaIN is thought to be similar to that of are uncertain. VaIN can occur alone or as a synchronous or cervical intraepithelial neoplasia (CIN), although there is metachronous lesion with cervical and vulvar HPV-related little information regarding this. The management of this intra epithelial or invasive neoplasia. Its association with intraepithelial neoplasia should be tailored according to the cervical intraepithelial neoplasia is found in 65% of cases, patient. After early treatment, VaIN frequently regresses, but with vulvar intraepithelial neoplasia in 10% of cases, while patients require careful long-term monitoring after initial for others, the association with concomitant cervical or therapy due to high risk of recurrence and progression. The vulvar intraepithelial neoplasias is found in 30-80% of cases. purpose of this review is to identify the best management of VaIN is often asymptomatic and its diagnosis is suspected in VaIN basing therapy on patients’ characteristics. cases of abnormal cytology, followed by colposcopy and colposcopically-guided biopsy of suspicious areas.